| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |



*Department of Medicine, Julius-Maximilians Universität, Würzburg, Germany;
Department of Physiology, Ludwig-Maximilians Universität, München, Germany;
Department of Experimental and Clinical Pharmacology and Toxicology, Albert-Ludwigs Universität Freiburg, Germany.
Correspondence to Prof. Dr. Jan Galle, Department of Medicine, University Hospital Würzburg, Joseph-Schneider-Str. 2, D-97080 Würzburg, Germany. Phone: 49-931-201-36331; Fax: 49-931-201-36502;
ABSTRACT. RhoA stimulates vascular tone by increasing smooth muscle Ca2+ sensitivity, e.g., in atherosclerosis. This study was an investigation of the influence of oxidized LDL (OxLDL), which accumulates in atherosclerotic plaques, on vascular tone induced by angiontensin II (AngII), with particular emphasis on the RhoA pathway. OxLDL had no influence on unstimulated vascular tone of isolated rabbit aorta, but it potentiated contractile responses induced by AngII. The Ca2+-antagonist felodipin partially prevented potentiation of contractile responses, whereas the AT1 receptor antagonist losartan blunted AngII responses in presence and in absence of OxLDL. Rho-kinase inhibition by Y27632 abolished potentiation of contractile responses, and RhoA inhibition by C3-like transferase partially prevented it, suggesting that OxLDL activated RhoA. Activation of RhoA was further analyzed by detection of its translocation to the cell membrane after stimulation with OxLDL. Western blot analysis of aorta homogenates, as well as direct visualization in cultured smooth muscle cells using confocal laser scan microscopy, revealed that OxLDL potently activated RhoA. The effect of OxLDL was mimicked by its compound lysophosphatidylcholine, and C3 inhibited both lysophosphatidylcholine and OxLDL-induced RhoA stimulation. In conclusion, OxLDL stimulates the RhoA pathway, resulting in potentiation of AngII-induced vasoconstriction. Lysophosphatidylcholine mimics the OxLDL effect, consistent with a causal role of this OxLDL compound. Stimulation of RhoA by OxLDL may contribute to vasospasm in atherosclerotic arteries. E-mail: J-C.galle@mail.uni-wuerzburg.de
This article has been cited by other articles:
![]() |
G. B. Kowalsky, F. J. Byfield, and I. Levitan oxLDL facilitates flow-induced realignment of aortic endothelial cells Am J Physiol Cell Physiol, August 1, 2008; 295(2): C332 - C340. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Parker, G. Roe, T. R. Grover, and S. H. Abman Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L976 - L982. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Brandes Roads to Dysfunction: Argininase II Contributes to Oxidized Low-Density Lipoprotein-Induced Attenuation of Endothelial NO Production Circ. Res., October 27, 2006; 99(9): 918 - 920. [Full Text] [PDF] |
||||
![]() |
H. Morawietz, S. Erbs, J. Holtz, A. Schubert, M. Krekler, W. Goettsch, O. Kuss, V. Adams, K. Lenk, F. W. Mohr, et al. Endothelial Protection, AT1 Blockade and Cholesterol-Dependent Oxidative Stress: The EPAS Trial Circulation, July 4, 2006; 114(1_suppl): I-296 - I-301. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhang, B. Rodrigues, and K. M. MacLeod Lysophosphatidylcholine Potentiates Phenylephrine Responses in Rat Mesenteric Arterial Bed through Modulation of Thromboxane A2 J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 355 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Musicki and A. L. Burnett eNOS Function and Dysfunction in the Penis Experimental Biology and Medicine, February 1, 2006; 231(2): 154 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming, A. Mohamed, J. Galle, L. Turchanowa, R. P. Brandes, B. Fisslthaler, and R. Busse Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKC{alpha} Cardiovasc Res, March 1, 2005; 65(4): 897 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Seasholtz and J. H. Brown RHO SIGNALING in Vascular Diseases Mol. Interv., December 1, 2004; 4(6): 348 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Seibold, D. Schurle, A. Heinloth, G. Wolf, M. Wagner, and J. Galle Oxidized LDL Induces Proliferation and Hypertrophy in Human Umbilical Vein Endothelial Cells via Regulation of p27Kip1 Expression: Role of RhoA J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3026 - 3034. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ott, D. Iwanciw, A. Graness, K. Giehl, and M. Goppelt-Struebe Modulation of the Expression of Connective Tissue Growth Factor by Alterations of the Cytoskeleton J. Biol. Chem., November 7, 2003; 278(45): 44305 - 44311. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673